MiMedx Group, Inc. (NASDAQ: MDXG) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences [Yahoo! Finance]
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences
Parker H. "Pete" Petit Issues Numerous Warnings to Business Leaders in The Second Edition of His Book: The Entrepreneur's Dilemma: The Weaponization and Politicization of Our Justice System [Yahoo! Finance]